Pacira BioSciences, Inc. (PCRX)
Return on assets (ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -99,560 | -90,731 | 63,593 | 70,470 | 41,955 | 6,983 | -4,568 | -10,455 | 15,909 | 20,882 | 39,235 | 38,440 | 41,981 | 61,624 | 174,083 | 147,733 | 145,523 | 126,121 | -10,085 | -86 |
| Total assets | US$ in thousands | 1,553,520 | 1,521,690 | 1,646,820 | 1,583,320 | 1,574,390 | 1,534,460 | 1,542,380 | 1,523,420 | 1,681,200 | 1,734,360 | 1,733,990 | 1,891,480 | 2,075,350 | 1,356,000 | 1,325,830 | 1,287,550 | 1,274,510 | 1,220,270 | 866,111 | 821,379 |
| ROA | -6.41% | -5.96% | 3.86% | 4.45% | 2.66% | 0.46% | -0.30% | -0.69% | 0.95% | 1.20% | 2.26% | 2.03% | 2.02% | 4.54% | 13.13% | 11.47% | 11.42% | 10.34% | -1.16% | -0.01% |
December 31, 2024 calculation
ROA = Net income (ttm) ÷ Total assets
= $-99,560K ÷ $1,553,520K
= -6.41%
Pacira BioSciences, Inc.'s return on assets (ROA) has shown fluctuations over the period provided. The ROA was negative for the first two quarters of 2020, indicating that the company was not effectively generating earnings from its assets during that time. From September 2020 to June 2021, the ROA showed substantial improvement, reaching double-digit percentages, which suggests that the company was able to utilize its assets more efficiently to generate profits.
However, the ROA started to decline from September 2021 onwards, indicating a decrease in the company's ability to generate earnings from its assets. The ROA remained positive but fluctuated at lower levels in the subsequent quarters, with negative ROA values recorded in the third and fourth quarters of 2024. These negative values suggest that the company's assets were not generating sufficient profits to cover its operational and financial obligations during those periods.
Overall, the trend in Pacira BioSciences, Inc.'s ROA indicates periods of both efficiency and inefficiency in utilizing its assets to generate earnings. Further analysis, in conjunction with other financial metrics, would be necessary to understand the underlying reasons for these fluctuations and to assess the company's overall financial performance and stability.
Peer comparison
Dec 31, 2024